Filing Details

Accession Number:
0001127602-12-025459
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-08-30 20:19:44
Reporting Period:
2012-08-29
Filing Date:
2012-08-30
Accepted Time:
2012-08-30 20:19:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
850693 Allergan Inc AGN Pharmaceutical Preparations (2834) 951622442
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1214127 Jr J Louis Lavigne 2525 Dupont Drive
Irvine CA 92612
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-03-09 4,800 $0.00 20,400 No 5 G Indirect By Lavigne Family Trust
Common Stock Acquisiton 2012-03-09 4,800 $0.00 4,800 No 5 G Indirect By Lavigne Survivor's Trust
Common Stock Disposition 2012-04-17 20,400 $0.00 0 No 5 G Indirect By Lavigne Family Trust
Common Stock Acquisiton 2012-04-17 20,400 $0.00 20,400 No 5 G Indirect By Rachel Lavigne Exmpt Bypass Trust
Common Stock Disposition 2012-08-29 15,000 $85.04 5,400 No 4 S Indirect By Rachel Lavigne Exmpt Bypass Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Indirect By Lavigne Family Trust
No 5 G Indirect By Lavigne Survivor's Trust
No 5 G Indirect By Lavigne Family Trust
No 5 G Indirect By Rachel Lavigne Exmpt Bypass Trust
No 4 S Indirect By Rachel Lavigne Exmpt Bypass Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 9,611 Direct
Footnotes
  1. Transfer of 4,800 shares held by the Lavigne Family Trust.
  2. Shares held by the Lavigne Family Trust. Reporting Person is trustee of the Lavigne Family Trust.
  3. Shares held by the Louis Lavigne Survivor's Trust. Reporting Person is sole trustee of the Louis Lavigne Survivor's Trust.
  4. Transfer of 20,400 shares held by the Lavigne Family Trust
  5. Shares held by the Rachel Lavigne Exmpt Trust. Reporting Person is sole trustee of the Rachel Lavigne Exmpt Trust.
  6. Includes 4,800 shares of the Issuer's common stock underlying the RSUs awarded.
  7. Includes shares acquired pursuant to dividend equivalent rights attached to RSUs previously granted to the Reporting Person.